echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Another first copy of Dongyang Sunshine "Entacapone Film" is about to be approved

    Another first copy of Dongyang Sunshine "Entacapone Film" is about to be approved

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 15th, the NMPA official website showed that Guangdong Dongyang Sunshine Pharmaceutical Co.


    Entacapone (trade name: Comtan) is a specific peripheral catecholamine-o-methyltransferase (COMT) inhibitor developed by Orion in Finland, which works by inhibiting COMT enzyme to reduce the metabolism of levodopa.


    Parkinson’s disease (PD) is a common chronic degenerative disease of the nervous system in the elderly.


    According to GlobalHealth Data's 2017 data, there are about 2.


    COMT inhibitors are clearly recommended by European, American and domestic treatment guidelines, and are first-line drugs that assist dopamine in the treatment of Parkinson's disease patients.


    The original research Entacapone was approved in China in May 2004 under the trade name Kedan.


    According to the Insight database, currently 4 domestic companies have begun to deploy the entacapone generic drug market.


    From the Insight database (http://db.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.